Please assess the completion status of the following clinical trial:

Trial Title: Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical stage 2, 3A or 3B (unresectable)~* Histologic evidence of non-small cell carcinoma~* Age \> 18 years~* Karnofsky performance status 70 or greater~* No prior radiation to the chest~* No previous chemotherapy~Exclusion Criteria:~* Clinical stage 1 or 4~* Previous malignancies except for non-melanoma skin cancer unless disease free for \> 3 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Proton therapy with chemotherapy (Type: EXPERIMENTAL): Induction Chemotherapy - Two cycles Taxol 200mg/m2 and Carboplatin AUC6 on day 1 and day 22. Weekly chemotherapy concurrent with radiotherapy Taxol 50mg/m2 and Carboplatin AUC 2 weekly for 5 weeks.~Proton therapy - 76 Gy in 5 weeks to lung tumor.

Based on this trial design, predict the completion outcome and termination type (if applicable).